Performance analysis of Perspective Therapeutics (CATX)
Annual Return
Over the past 3 years, CATX has had an average annual return of -13.10%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, CATX has had an average annual return of -17.21%, underperforming the benchmark SPY, which returned +14% annual.
Over the past 10 years, CATX has had an average annual return of -8.39%, underperforming the benchmark SPY, which returned +15.53% annual.
Since Nov 10, 2005, CATX has had an average annual return of -12.11%, underperforming the benchmark SPY, which returned +11.27% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +30.24% | -13.76% | -20.69% | +62.47% | -36.18% | -13.83% | -27.47% | +106.80% | -25.00% | -31.05% | -38.14% | -35.80% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | ||
| +192.14% | -35.91% | +18.16% | -41.61% | +26.99% | +345.15% | -90.05% | -58.98% | -32.41% | +42.16% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +37.85% | +42.53% | -22.76% | -6.48% | +1.05% | -9.18% | +30.24% | ||||||
| 2025 | +11.36% | -21.70% | -23.30% | +14.83% | +5% | +33.93% | +11.56% | -12.48% | +2.12% | -20.51% | -13.83% | +16.92% | -13.76% |
| 2024 | +101.52% | +11.15% | +32.18% | +41.19% | -17.85% | -27.75% | +36.42% | +16.16% | -15.49% | -11.54% | -63.17% | -26.73% | -20.69% |
| 2023 | +53.61% | -3.89% | +74.72% | -2.48% | -14.84% | +26.08% | -14.66% | -28.98% | -32.37% | -5.40% | -1.57% | +57.60% | +62.47% |
| 2022 | -1.97% | -7.38% | +3.19% | -11.94% | -11.64% | +9.39% | +6.77% | +12.06% | -37.79% | +33.04% | +29.67% | -37.66% | -36.18% |
| 2021 | +277.89% | -17.64% | -22.15% | -15.35% | -13.27% | -0.25% | -13.99% | -6.76% | -1.43% | -4.12% | -25.46% | -14.03% | -13.83% |
| 2020 | +29.03% | -7.52% | -28.39% | +26.47% | +7.31% | -22.13% | +13.57% | +3.37% | -11.33% | -30.97% | -6.97% | +20.16% | -27.47% |
| 2019 | +50% | -13.27% | -6.41% | +12.29% | +12.19% | -10.86% | -9.83% | -10.76% | -3.09% | -3.03% | +93.42% | +3.40% | +106.80% |
| 2018 | +20.03% | -12.43% | -0% | +11.89% | +10.63% | -13.53% | +37.87% | -17.52% | +1.40% | -11.31% | -10.09% | -27.50% | -25.00% |
| 2017 | +3.43% | -9.95% | +9.25% | +3.20% | -9.88% | +13.85% | -6.37% | -9.42% | -2.50% | -11.94% | -1.12% | -11.11% | -31.05% |
Drawdown analysis of Perspective Therapeutics (CATX)
The maximum drawdown for the CATX was -98.18%, occurring on Mar 25, 2009. This drawdown has not yet recovered.
The current CATX drawdown is -95.66%.
Since Nov 10, 2005 CATX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.18% | Dec 15, 2005 | 822 | Mar 25, 2009 | Ongoing | Ongoing | Ongoing |
| -17.42% | Dec 1, 2005 | 6 | Dec 9, 2005 | 2 | Dec 13, 2005 | 8 |
| -4.38% | Nov 11, 2005 | 6 | Nov 21, 2005 | 7 | Dec 1, 2005 | 13 |